Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease thromboembolism
Phenotype C0242379|lung cancer
Sentences 9
PubMedID- 24574864 The incidence and predictors of thromboembolic events in patients with lung cancer.
PubMedID- 25921284 We investigated the clinical significance of the absolute monocyte count (amc) as a predictor of the response to anticoagulation and survival in lung cancer patients with venous thromboembolism (vte).
PubMedID- 25129368 Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
PubMedID- 23836248 Background: clinicians are frequently confronted by thromboembolic events in patients with lung cancer, yet few data are available about their incidence.
PubMedID- 20456756 Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the protecht and topic-2 studies.
PubMedID- 24524817 Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
PubMedID- 25312667 Objective: to explore the clinical characteristics and outcomes of lung cancer patients with venous thromboembolism (vte).
PubMedID- 22859911 Risk of venous thromboembolism in people with lung cancer, with pooled incidence rates and 95% confidence intervals obtained from random effects meta-analysis.
PubMedID- 24679344 thromboembolism in lung cancer - an area of urgent unmet need.

Page: 1